Brainfarma Industria Química e Farmacêutica S/A
Brainfarma Industria Química e Farmacêutica S/A
Explore linked clinical trials.9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dermal and Ophthalmological Acceptability and Comedogenicity Assessment of a Cosmetic Product | Acne Prone Skin; Oily Skin | Recruiting | Not applicable | 2026-09-30 | NCT07848555 | |
| Dermal Acceptability Evaluation in Sensitive Skin | Sensitive Skin | Recruiting | Not applicable | 2026-09-30 | NCT07848347 | |
| Pediatric Acceptability Evaluation of a Cosmetic Product | Pediatric Safety | Recruiting | Not applicable | 2026-09-24 | NCT07839104 | |
| Dermatological Acceptability and Efficacy in Improving Xerosis, Skin Hydration, and Barrier Function | Dry Skin; Xerosis | Recruiting | Not applicable | 2026-09-16 | NCT07820943 | |
| Efficacy Evaluation of a Cosmetic Product for Facial Hyperpigmentation | Hyperpigmentation, Melanosis, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Recruiting | Not applicable | 2026-09-16 | NCT07769268 | |
| Evaluation of Dermal Acceptability and Comedogenic and Acnegenic Potential of a Cosmetic Product | Oily Skin | Recruiting | Not applicable | 2026-09-16 | NCT07768800 | |
| Dermal and Ophthalmological Acceptability Assessment in Sensitive Skin | Sensitive Skin | Recruiting | Not applicable | 2026-09-11 | NCT07771998 | |
| Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia | Diabetes Complications, Neuralgia, Postherpetic, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, diabetic neuropathy, endocrine system disorder, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder | Recruiting | Phase 3 | 2026-07-20 | NCT07712913 | |
| Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving Symptoms of the Common Cold and Flu in Adults | Airway Obstruction, Infections, Nasal Obstruction, Picornaviridae infectious disease, RNA Virus Infections, Respiration Disorders, common cold, influenza, nasal disorder, otorhinolaryngologic disease, respiratory failure, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 3 | 2026-06-16 | NCT07626437 |